Skip to Content
Søk Menu
Neurologi
Välkommen till Neurologi

Få höjdpunkter och de senaste nyheterna från neurologi

Seneste nyt fra neurologi

Towards Personalized MS Therapy: microRNAs as Early Indicators of Cladribine Response

  • / Jan Andreasen

Neurology

  • Meet the Experts
  • 2025
Få tillgang

Possible Biomarkers for Progression Independent of Relapse Activity Identified in RMS

/ Jan Andreasen
ECTRIMS25

Cladribine Shows a Robust Safety Profile – Both as First-Line and Subsequent Therapy in MS

/ Neurologi / Jan Andreasen

EAN 2025: GLP-1 Therapy Shows Promise in Reducing Migraine Burden

/ Neurologi / Amanda Feldballe Bernholm

EAN 2025: GPT-4o Can’t Replace Doctors - But It Can Reduce Delays and Streamline the Treatment Process

/ Neurologi / Jan Andreasen

Prospects for the Use of Antibodies Against Parkinson’s Disease: A Multi-Edged Sword?

/ Neurologi / Daniel E. Otzen / Nikos Hatzakis / Céline Galvagnion / Martin Lauritzen / Krzysztof Kucharz
Se oversigt

ECTRIMS | Kongres

Vi publicerar de viktigaste höjdpunkterna från ECTRIMS i form av sammanfattningar, onlineartiklar och MEDtalks med internationella och nationella nyckelopinionsledare.

Se allt innehåll

Följ med i nyheter från kongresser 2025/2026

Alzheimers

EAN 2025: Transforming the Diagnostic Pathway in the Era of Disease-Modifying Therapies for Alzheimer’s Disease

/ Neurologi / Kristian Steen Frederiksen

Positive Clinical Effects in the Early Stages of Alzheimer’s Disease: A Focus on Disease-Modifying Therapies

/ Neurologi / BestPractice Nordic

The Risk of Alzheimer's Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

/ Neurologi / Anne Koivisto

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer's and Dementia

/ Neurologi / Eino Solje

Mechanistic Exploration and the Development of New Biomarkers for Alzheimer’s Disease – Focusing on the Brain ‘Garbage’ Clearance System

/ Neurologi / Janet Jianying Zhang / He-Ling Wang / Anne-Brita Knapskog / Geir Selbæk / Evandro Fei Fang
Se oversigt

Myasthenia Gravis

EAN 2025: A Fundamental Shift in Myasthenia Gravis Treatment on the Horizon

/ Neurologi / Nils Erik Gilhus

EAN 2025: Early Add-On Therapy Shows Benefit in Myasthenia Gravis

/ Neurologi / Menekse Oeztuerk

Promising Advances in Myasthenia Gravis Treatment and Pregnancy Outcomes – Insights from Nordic Evening at EAN 2024

/ Neurologi / BestPractice Nordic

Prognostic Factors for Myasthenia Gravis

/ Neurologi / Sini Laakso

EAN 2024: Highlights Regarding Myasthenia Gravis

/ Neurologi / Nils Erik Gilhus
Se oversigt
Gloria Dalla Costa

ECTRIMS 2025: Ultra-Processed Food Intake is Linked to Increased MS Disease Activity

/ Gloria Dalla Costa
ECTRIMS25 Play the Video
Linda Forsberg

ECTRIMS 2025: Swedish Real-World MS Data Demonstrates Long-Term Safety and Effectiveness of Cladribine

/ Linda Forsberg
ECTRIMS25MS Play the Video
Faisal Mohammad Amin

EAN 2025: New Insights into Headache Disorders – From Prognosis to Potential Biomarkers

/ Faisal Mohammad Amin
EAN25Migrän Play the Video
Lanfranco Pellesi

Comparing Gepants for Acute Migraine Treatment

/ Lanfranco Pellesi
Migrän Play the Video
Marte Helene Bjørk

EAN 2025: First Seizure Clinics – Time Matters in Epilepsy

/ Marte-Helene Bjørk
EAN25Epilepsi Play the Video
Andrea Carmine Belin

Patients With Cluster Headache Have a High Level of Sleep Disturbance and Burnout

/ Andrea Carmine Belin
Huvudvärk Play the Video
Load more
Back to top